BRIC Diabetes Treatment and Prevention Market Size was valued at USD 4.82 Billion in 2023. The Global BRIC Diabetes Treatment and Prevention industry is projected to grow from USD 5.47 Billion in 2024 to USD 14.95 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 14.98% during the forecast period (2024 - 2032).
Diabetes is a chronic disease characterized by elevated levels of blood glucose which leads to serious damage to the heart, eyes, kidneys, blood vessels and nerves. The most common of diabetes is type 2 diabetes which occurs when the body becomes resistant to insulin or doesn't make enough insulin. In the past three decades the prevalence of type 2 diabetes has risen dramatically in countries of all income levels.
Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition in which the pancreas produces little or no insulin by itself. The market of diabetes treatment and prevention is increasing due to an increase in the prevalence of diabetes, changing lifestyle and increasing use of insulin for the treatment of diabetes. Increase awareness regarding prevention and treatment of diabetes favor the growth of this market.
Study objectives:
Figure 1: Global Diabetes Treatment and Prevention Market, by type: 
BRICS Diabetes Treatment and Prevention Market Key Players:
on the basis of type of diabetes which includes type 1 diabetes, type 2 diabetes and gestational diabetes.
On the basis of treatment the market is segmented into medication, gene therapy
On the basis of devices, Blood Glucose Meters and Strips, Continuous Glucose Monitors (CGMs), Injection Pens, Insulin Pump, others.
On the basis of end users the market is segmented into hospitals, clinics, pharmaceutical companies and other end users.
Figure 2: Research Methodology 
Diabetes treatment and prevention market consists of four regions namely Brazil, Russia, India, China and South Africa. China is the largest market. India is second largest and fastest growing market. The market shows steady growth in Brazil and Russia.
The report for diabetes treatment and prevention market of Market Research Future comprises of extensive primary research along with detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value & volume, technological advancement, macro economical, and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Diabetes drugs manufacturers
Diabetes drug suppliers
Contract Research Organizations (CROs)
Research and Development (R&D) Companies
Academic Medical Institutes and Universities
| Report Attribute/Metric | Details |
| Market Size | USD 14.95 Billion |
| CAGR | 14.98% 2024-2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Devices, Treatment and End User |
| Geographies Covered | America, Europe, Asia Pacific and Middle East & Africa |
| Key Vendors | Abbott Laboratories (U.S), Bayer AG (Germany), Eli Lily & Company (U.S), Medtronic (U.S), AstraZeneca Plc. (U.K), Lifescan (U.S), Terumo Medical Corporation (Japan) and Roche Holding AG (Switzerland). |
| Key Market Opportunities | The prevalence of type 2 diabetes has risen dramatically in countries |
| Key Market Drivers | Diabetes treatment and prevention is increasing due to an increase in the prevalence of diabetes |
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
